Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY23 Earnings Presentation
13 slides from Amrutanjan Health Care's earnings presentation, Aug 13, 2022
Slide 1: Exchange filing cover letter for investor presentation
August 12, 2022 AHCL/ SE/ 19 /2022-23 The National Stock Exchange of lndialimited BSE Limited Department of Corporate Services " Exchange Plaza", C-1, Block G Bandra-Kurla Complex, Bandra (E) 1st Floor, P.J . Towers, Dalal Street, Mumbai 400 051 Mumbai 400 001 Scrip Code: 590006 Symbol: AMRUTANJAN D
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter ended 30th June 2022 Date: 12th August 2022
Slide 3: Contents
Contents a. Business Update b. Q1 FY23 Performance c. Way Forward Investor Presentation | Quarter Ended 30th June 2022 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30th June 2022 3
Slide 5: Business Update
Business Update • The head ache category has degrown first time in q1(source: Nielsen) and we experienced the same • Even with the slow down, our current year balm sales still remain the 2nd all time highest ever • We are focusing on executing our long stated strategies of penetration in weak market
Slide 6: Q1 FY23 Performance
Q1 FY23 Performance Investor Presentation | Quarter Ended 30th June 2022 5
Slide 7: Financials – Q1 FY23
Financials – Q1 FY23 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 86.89 12.06 78.66 16.29 5.25 3.66 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Investor Presentation | Quarter Ended 30th June 2022 6
Slide 8: Expenses – Q1 FY23
Expenses – Q1 FY23 (Rs. in Crores) Employee Benefit Expenses 12.11 12.25 Q1 FY23 Q1 FY22 Advertisement & Selling Expenses Other Expenses 10.63 9.89 9.32 8.28 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Investor Presentation | Quarter Ended 30th June 2022 7
Slide 9: Financials – Q1 FY23 – OTC Division
Financials – Q1 FY23 – OTC Division (Rs. in Crores) Gross Sales - OTC 74.59 68.83 Notes: • Key raw material prices excluding Menthol crystal price are higher Q1 FY23 Q1 FY22 when compared to Q1 FY22. • The prices of packing materials are Gross Sales - Comfy higher when compared to Q1 FY22. 16.86 • A
Slide 10: Financials – Q1 FY23 – Beverage Division
Financials – Q1 FY23 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 12.02 9.22 Notes: • Raw Material & Packing Material prices are higher when compared to Q1 FY23 Q1 FY22 Q1 FY22. • Advertisement spend is at 1.35 cr Gross Sales - Electro Plus for Q1 FY23 against 1.77 cr for Q1 8.96 FY22
Slide 11: Way Forward
Way Forward Investor Presentation | Quarter Ended 30th June 2022 10
Slide 12: Way Forward
Way Forward We remain focused on executing our key priorities: • Expand distribution • Go global • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter Ended 30th June 2022 11
Slide 13: Investor Presentation | Quarter Ended 30th June 2022
Investor Presentation | Quarter Ended 30th June 2022 12
Amrutanjan Health Care — Q1 FY23 Earnings Presentation on 6ix